Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03678116 · ClinicalTrials.gov registry record · NA

Effects of a Thermogenic Dietary Supplement on Metabolic, Hemodynamic, and Mood Responses

A NA study of Blood Pressure and Mood, sponsored by University of Mary Hardin-Baylor.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT03678116 is a NA study of Blood Pressure and Mood that has completed, run by University of Mary Hardin-Baylor. The registered enrollment target is 14 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03678116, a NA study of Blood Pressure and Mood, has completed, sponsored by University of Mary Hardin-Baylor.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

This a randomized, double blind, placebo controlled, crossover design study which measures the effect of an available thermogenic dietary supplement on resting energy expenditure (REE), blood pressure and heart rate, and mood changes in moderate caffeine consumers. Participants will complete baseline measurements then ingest one of three pills. Once the pill is ingested, subjects will complete four REEs along with heart rate and blood pressure and appropriate questionnaires. Participants will return two more times, each after a one week washout period, and complete the same protocol with the remaining supplements.

Interventions

  • DRUG Sugar Pill (placebo)
  • DIETARY_SUPPLEMENT Caffeine (plus Teacrine and Cayenne)
  • DIETARY_SUPPLEMENT Caffeine (plus Teacrine)

Study Locations (1)

Texas

  • UMHB Human Performance Lab - Belton

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2018-07-23
Est. Completion 2018-10-31
Phase NA

Sponsor

University of Mary Hardin-Baylor

10 total trials

What the Registry Record Tells You About NCT03678116

The ClinicalTrials.gov registry entry for NCT03678116 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (95% lower). The listed sponsor is University of Mary Hardin-Baylor, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Blood Pressure appearing as the primary indexed condition, and to 3 interventions - of which Sugar Pill (placebo) is the first listed.

NCT03678116 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03678116 about?

NCT03678116 is a clinical study titled "Effects of a Thermogenic Dietary Supplement on Metabolic, Hemodynamic, and Mood Responses". This a randomized, double blind, placebo controlled, crossover design study which measures the effect of an available thermogenic dietary supplement on resting energy expenditure (REE), blood pressure and heart rate, and mood changes in moderate caffeine consumers. Participants will complete baselin...

What is the current status of trial NCT03678116?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2018-07-23. Estimated completion is 2018-10-31.

What conditions does trial NCT03678116 study?

This clinical trial studies the following conditions: Blood Pressure, Mood, Energy Metabolism, Heart Rate.

What interventions are being tested in trial NCT03678116?

The interventions under investigation include: Sugar Pill (placebo) (DRUG), Caffeine (plus Teacrine and Cayenne) (DIETARY_SUPPLEMENT), Caffeine (plus Teacrine) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03678116?

This trial is sponsored by University of Mary Hardin-Baylor, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03678116 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.